TL;DR
Alphabet’s Verily is seeking approval from the EPA to release 64 million Wolbachia-carrying male mosquitoes in Florida and California to suppress the Aedes aegypti population. Previous Debug trials achieved up to a 95% reduction in mosquito bites in Fresno and over 70% in dengue in Singapore.
Indeed, the health and life sciences unit of Google parent Alphabet sought permission from the US Environmental Protection Agency to release up to 64 million lab-grown mosquitoes over two years in Florida and California. The proposal, presented as part of the company’s Debug initiative, involves deploying Wolbachia-carrying Aedes aegypti male mosquitoes to areas where the species transmits dengue fever, Zika virus, yellow fever and chikungunya. EPA is reviewing the application Under an experimental use permit with a public comment period that runs through early June.
This approach is elegant in its biology. Wolbachia is a naturally occurring bacterium found in about 60% of insect species, but not in Aedes aegypti. When males carrying laboratory-grown Wolbachia mate with wild-type females, the resulting eggs do not develop. Males don’t bite, don’t transmit disease, and can’t breed with each other, making the release self-limiting. Each generation of released males reduces the wild population without introducing permanent genetic changes or synthetic chemicals into the environment.
Results so far
Debug has been field testing since 2017. In Fresno, California, the program reduced biting female Aedes aegypti populations by 68% in its first year, more than 95% in 2018, and 84% in 2019. The results place it among the population control methods based on biotechnology Tested at scale in the US.
In Singapore, where the government implemented Wolbachia-based mosquito control as part of a national dengue epidemic strategy, the release of sterile males resulted in 80% to 90% suppression of Aedes aegypti populations and a more than 70% reduction in dengue cases within six to 12 months. The World Mosquito Program, which operates independently of Verily, has deployed Wolbachia in 14 countries using a different approach that infects both male and female mosquitoes to create self-sustaining Wolbachia populations in the wild.
💜 of EU technology
The latest rumblings from the EU tech scene, a story from our wise founder Boris and some questionable AI art. Free in your inbox every week. Register now!
How does one really measure it?
The problem with mosquito releases is logistics, not biology. Releasing millions of male mosquitoes requires mass breeding, sorting them from female mosquitoes with near-perfect precision (releasing females will increase biting), and distributing them over target areas at the right density and timing. Verily applies the artificial intelligence capabilities of its parent company to each of these steps.
The Debug program uses artificial intelligence-powered mosquito sorting systems that can separate males from females using computer vision, automated breeding technology that maintains colony health on an industrial scale, and special release platforms, including drones and ground-based dispensers, that distribute mosquitoes to target areas. The 64 million figure drops to 16 million per state per year over the two-year permit period.
Controversy
Not everyone likes the idea of ​​a tech company releasing tens of millions of insects into the wild. The intersection of AI, biotechnology, and public health corporate involvement in environmental interventions raises questions about long-term environmental impacts and public consent. Critics have raised concerns about whether the reduction of one mosquito species could affect the food chain, whether Wolbachia could spread to non-target species, and whether corporate-led biological interventions would require more stringent oversight than the current EPA permitting process provides.
Proponents argue that Aedes aegypti is an invasive species in the Americas, not part of the native ecosystem, and that its removal would have minimal environmental impact. The species causes hundreds of millions of dengue infections worldwide each year, with cases increasing dramatically as climate change spreads mosquitoes into previously temperate regions. Artificial intelligence-based approaches to biological and medical problems gives results that traditional methods try to match.
Why it’s important for tech
Debug is one of the few projects that survives from Verily’s original mission to apply the technology to the life sciences at scale. Alphabet has repeatedly restructured its health ambitions, halting or suspending various initiatives. While most of Big Tech’s resources are focused on AI infrastructureVerily’s mosquito program represents a different kind of application technology: using automation, computer vision and logistics software to solve a public health problem that kills hundreds of thousands of people every year.
If the EPA approves the permit, Florida and California will be the largest U.S. implementation of Wolbachia-based mosquito control to date. A decision is expected after the public comment period closes, with releases potentially beginning in late 2026 or early 2027.
